HONG KONG, Dec 12, 2023 – (ACN Newswire) – The innovative medical device company in China with a main focus on the field of minimally-invasive interventional cryotherapy, Cryofocus Medtech (Shanghai) Co., Ltd. (the “Company” or “Cryofocus Medtech”, stock code: 6922.HK), on a voluntary basis to announce that the Company has obtained the marketing approval for its self-developed Atrial Fibrillation Cryoablation System (“AF Cryoablation System”) from the National Medical Products Administration of the People’s Republic of China (the “NMPA”).The AF Cryoablation System of Cryofocus Medtech…
Read More
